- 全部删除
- 您的购物车当前为空
Talarozole (R115866) 是一种口服性全反式维甲酸代谢阻断剂,可抑制 CYP26A1 和 CYP26B1,IC50 分别为 5.4 和 0.46 nM。它用于治疗痤疮、牛皮癣和其他角化疾病。
Talarozole (R115866) 是一种口服性全反式维甲酸代谢阻断剂,可抑制 CYP26A1 和 CYP26B1,IC50 分别为 5.4 和 0.46 nM。它用于治疗痤疮、牛皮癣和其他角化疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 497 | In stock | |
5 mg | ¥ 1,070 | In stock | |
10 mg | ¥ 1,490 | In stock | |
25 mg | ¥ 2,420 | In stock | |
50 mg | ¥ 3,480 | In stock | |
100 mg | ¥ 4,890 | In stock | |
200 mg | ¥ 6,780 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 893 | In stock |
产品描述 | Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.Talarozole for the treatment of acne, psoriasis and other keratinization disorders. |
靶点活性 | CYP26B1/A1:0.46/5.1 nM (IC50) |
别名 | 他拉罗唑, R115866 |
分子量 | 377.51 |
分子式 | C21H23N5S |
CAS No. | 201410-53-9 |
Smiles | CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1 |
密度 | 1.26 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 36 mg/mL (95.36 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容